glp 1 agonist eli lilly FDA approves Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic Lilly's Double-Beat Widens the GLP-1

Orlistats typical side effects are oily stools or flatulence, especially with fatty meals

We also found that cost remains a substantial barrier to sustained use, with nearly 13% of patients citing affordability as a reason for stopping

JAMA 2024;331:3848.PubMedPMC 95

Lilly said buying the vials directly from the company cuts costs by removing third-party supply chain entities and allowing patients to access savings directly outside of insurance. According to Lilly, the new, cheaper product fulfills two goals: Widening access to the sometimes tough-to-get meds, and thwarting what it says are potential unsafe copycat versions made by compounding pharmacies

New York: Medscape

Drugs under the same class were regarded as one treatment node and pooled effect sizes were estimated regardless of drug dose